Assignee
REVANCE THERAPEUTICS INC
US·19 granted patents·48 pending applications·147 citations·filing 2001–2025
Top patents by PatentIndex Score
67 records- 0197US9469849B2Methods and systems for purifying non-complexed botulinum neurotoxinREVANCE THERAPEUTICS INC·Filed 2015·Granted Oct 18, 2016·23 cites·67 claims
- 0296US9211248B2Compositions and methods for topical application and transdermal delivery of botulinum toxinsREVANCE THERAPEUTICS INC·Filed 2013·Granted Dec 15, 2015·21 cites·76 claims
- 0395US10201594B2Compositions and methods for safe treatment of rhinitisREVANCE THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·14 cites·8 claims
- 0495US10111939B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·16 cites·38 claims
- 0594US10080786B2Methods for treating pain by topical application and transdermal delivery of botulinum toxinREVANCE THERAPEUTICS INC·Filed 2015·Granted Sep 25, 2018·12 cites·45 claims
- 0692US9901627B2Topical ocular preparation of botulinum toxin for use in ocular surface diseaseREVANCE THERAPEUTICS INC·Filed 2015·Granted Feb 27, 2018·5 cites·31 claims
- 0792US8022179B2Compositions and methods for topical application and transdermal delivery of an oligopeptideREVANCE THERAPEUTICS INC·Filed 2006·Granted Sep 20, 2011·17 cites·26 claims
- 0889US10744078B2Compositions and methods for topical application and transdermal delivery of botulinum toxinsREVANCE THERAPEUTICS INC·Filed 2018·Granted Aug 18, 2020·5 cites·20 claims
- 0988US7807780B2Multi-component biological transport systemsREVANCE THERAPEUTICS INC·Filed 2001·Granted Oct 5, 2010·28 cites·6 claims
- 1088US2024108700A1Methods of Treating a Spastic Disorder in a Subject Having Underlying Condition(s)REVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1188US2024382571A1Albumin-Free Botulinum Toxin FormulationsREVANCE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1288US2024100135A1Methods of Treating an Optic Disease in a SubjectREVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1387US2024000906A1Methods of Treating or Preventing Migraine or Repetitive Occurrence of Common Migraine Headaches in a Subject Having Underlying Condition(s)REVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1485US11351232B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2018·Granted Jun 7, 2022·1 cites·19 claims
- 1585US9950042B2Extended length botulinum toxin formulation for human or mammalian useREVANCE THERAPEUTICS INC·Filed 2015·Granted Apr 24, 2018·4 cites·17 claims
- 1683US2024058628A1Injectable botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1781US10441641B2Botulinum toxin and the treatment of primary disorders of mood and affectREVANCE THERAPEUTICS INC·Filed 2015·Granted Oct 15, 2019·1 cites·9 claims
- 1879US2020078450A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1978US2025064905A1Injectable botulinum toxin formulations and methods of use thereof having high response rate and long effect durationREVANCE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2077US11911449B2Albumin-free botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2021·Granted Feb 27, 2024·0 cites·14 claims
- 2177US11466262B2Methods and systems for purifying non-complexed botulinum neurotoxinREVANCE THERAPEUTICS INC·Filed 2019·Granted Oct 11, 2022·0 cites·23 claims
- 2277US2021308236A1Botulinum toxin and the treatment of primary disorders of mood and affectREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2376US12257293B2Methods of treatment for cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2021·Granted Mar 25, 2025·0 cites·9 claims
- 2476US2021252116A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2576US2021283228A1Botulinum toxin and the treatment of primary disorders of mood and affectREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2675US2017143807A9Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2774US2010166689A1Compositions and Methods for Treating HyperpigmentationREVANCE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2873US2021069224A1Compositions and Methods for Topical and Diagnostic and Therapeutic TransportREVANCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2973US2020101097A1Compositions and Methods for Topical and Diagnostic and Therapeutic TransportREVANCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3072US2025319168A1Methods of treatment for cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3171US2025332232A1Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disordersREVANCE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3269US2017165331A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3369US2017165330A1Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3468US2024216486A1Injectable botulinum toxin methods for treating headachesREVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3567US11471708B2Injectable botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2019·Granted Oct 18, 2022·0 cites·13 claims
- 3667US2021189326A1Methods and kits for topical application, removal, and inactivation of therapeutic or cosmetic toxin compositionsREVANCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3767US2017333537A9Botulinum Toxin and the Treatment of Primary Disorders of Mood and AffectREVANCE THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3866US2022062400A1Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic EffectREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3966US2023390368A1Methods of Treating Cervical Dystonia in a Subject Having Underlying Condition(s)REVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4064US2020345819A1Compositions and Methods for Safe Treatment of RhinitisREVANCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4164US2017029795A1Methods and Systems for Purifying Non-Complexed Botulinum NeurotoxinREVANCE THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4264US2014120077A1Compositions and Methods for Safe Treatment of RhinitisREVANCE THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4363US2020179498A1Methods of treatment for cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4462US2020384090A1Injectable botulinum toxin formulations and methods of use thereof having high response rate and long effect durationREVANCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4559US10857215B2Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory bedsREVANCE THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2020·0 cites·29 claims
- 4658US2018214717A1Injectable botulinum toxin formulationsREVANCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4757US2023210963A1Injectable botulinum toxin methos for treating headachesREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4857US2008226551A1Transport Molecules Using Reverse Sequence HIV-TAT PolypeptidesREVANCE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 4957US2025268996A1Methods of and compositions for treatment of upper limb spasticityREVANCE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 5057US2010093639A1Transport Molecules Using Reverse Sequence HIV-TAT PolypeptidesREVANCE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when REVANCE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →